Healthcare Master Fund Ltd Broadfin serves as Executive at Aegerion Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Healthcare Master Fund Ltd Broadfin has executed 33 insider transactions totaling $42.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 11, 2022 involved exercising options for 2,422,222 shares valued at $4.4M.
Healthcare Master Fund Ltd Broadfin currently holds 7,588,395 shares of Aegerion Pharmaceuticals, Inc. (AEGR), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Healthcare Master Fund Ltd Broadfin has been a net seller of AEGR stock. They have purchased $7.9M and sold $34.3M worth of shares.
Healthcare Master Fund Ltd Broadfin's most recent insider trade was on Feb 11, 2022, when they sold 2,422,222 shares at $1.80 per share.
Get notified when new Form 4 filings are submitted
| $3.25 |
| Discretionary |
| May 12, 2021 | BDSI | $324.0K | Purchase | 100,000 | $3.24 | Discretionary |
| May 11, 2021 | BDSI | $474.0K | Purchase | 150,000 | $3.16 | Discretionary |
| Nov 18, 2019 | BDSI | $7.2M | Conversion | 4,000,000 | $1.80 | Discretionary |
| Nov 18, 2019 | BDSI | $8.8M | Sale | 1,500,000 | $5.90 | Discretionary |
| Nov 18, 2019 | BDSI | $1.7M | Sale | 293,757 | $5.90 | Discretionary |
| Nov 15, 2019 | BDSI | $13.3M | Sale | 2,206,243 | $6.04 | Discretionary |
| Jan 31, 2019 | AVDL | $0 | Award | 27,900 | $N/A | Discretionary |
| Dec 13, 2017 | REPH | $80.7K | Sale | 8,237 | $9.80 | Discretionary |
| Dec 13, 2017 | REPH | $97.4K | Sale | 9,900 | $9.84 | Discretionary |
| Dec 12, 2017 | REPH | $250.0K | Sale | 25,000 | $10.00 | Discretionary |
| Dec 12, 2017 | REPH | $490.0K | Sale | 50,000 | $9.80 | Discretionary |
| Dec 12, 2017 | REPH | $989 | Sale | 100 | $9.89 | Discretionary |
| Dec 5, 2017 | REPH | $1.0M | Sale | 100,000 | $10.00 | Discretionary |
| Nov 24, 2017 | REPH | $54.5K | Sale | 5,800 | $9.39 | Discretionary |
| Nov 24, 2017 | REPH | $19.1K | Sale | 2,051 | $9.31 | Discretionary |
| Nov 24, 2017 | REPH | $27.1K | Sale | 2,913 | $9.32 | Discretionary |
| Nov 24, 2017 | REPH | $55.3K | Sale | 5,900 | $9.37 | Discretionary |
| Nov 24, 2017 | REPH | $13.7K | Sale | 1,450 | $9.48 | Discretionary |
| Nov 22, 2017 | REPH | $28.9K | Sale | 3,088 | $9.36 | Discretionary |
| Nov 22, 2017 | REPH | $455.1K | Sale | 48,566 | $9.37 | Discretionary |
| Nov 21, 2017 | REPH | $22.9K | Sale | 2,440 | $9.37 | Discretionary |
| Nov 21, 2017 | REPH | $950.0K | Sale | 100,000 | $9.50 | Discretionary |
| Nov 2, 2017 | CORI | $1.7M | Sale | 150,000 | $11.05 | Discretionary |
| Oct 4, 2017 | CORI | $2.4M | Sale | 218,100 | $11.01 | Discretionary |
| Jun 23, 2017 | AVDL | $1.7M | Sale | 161,000 | $10.60 | Discretionary |
| Jun 22, 2017 | AVDL | $1.1M | Sale | 100,000 | $10.80 | Discretionary |
| May 19, 2017 | PETX | $5.5M | Exercise | 729,500 | $7.50 | Discretionary |
| Dec 13, 2016 | REPH | $3.9M | Purchase | 650,000 | $6.00 | Discretionary |